The productivity burden of breast cancer in Australia

Breast cancer exerts a considerable burden on an individual's health but also impacts society more broadly through lost work productivity. This study aimed to measure the quality of life and productivity burden among Australian females of working age diagnosed with breast cancer in 2022. Over a ten-year period from 2022 to 2031, it is predicted that breast cancer will result in the loss of 4286 years of life lived and 15,597 quality-adjusted life years. It is also predicted that 16,403 productivity-adjusted life years will be lost, equating to AU$3.26 billion in lost GDP. Breast cancer significantly impacts the health and economic welfare of Australian females of working age. Funding initiatives and programs which accelerate recovery and integration back into the workforce are likely to be economically beneficial.